Review ArticleReview

PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy

Long Jia, Qi Zhang and Rongxin Zhang
Cancer Biology & Medicine May 2018, 15 (2) 116-123; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0086

Article Information

vol. 15 no. 2 116-123
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2017.0086
Published By 
Cancer Biology & Medicine
History 
  • Received July 15, 2017
  • Accepted February 1, 2018
  • Published online May 1, 2018.
Copyright & Usage 
Copyright: © 2018, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Long Jia1,
  2. Qi Zhang2 and
  3. Rongxin Zhang⇑1,3
  1. 1Laboratory of Immunology and Inflammation, Department of Immunology and Research Center of Basic Medical Sciences, Key Laboratory of Immune Microenvironments and Diseases of Educational Ministry, Tianjin Medical University, Tianjin 300070, China
  2. 2Institute of Integrative Medicines for Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin 300100, China
  3. 3Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China
  1. Correspondence to: Rongxin Zhang, E-mail: rxzhang{at}tmu.edu.cn or rongxinz{at}yahoo.com
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords